2662512-02-7
2662512-02-7
Chemical Structure
BTK-IN-31
- CAS No.: 2662512-02-7
- Formula:C24H23FN4O3
- Molecular Weight:434.46
InChIKey: HBZJYWPPPVDNBJ-MAUKXSAKSA-N
SMILES: NC1=NC=CN2C([C@H]3CC[C@@H](OC3)CO)=NC(C4=C(C=C(C=C4)OC5=CC=CC=C5)F)=C12
Biological Activity: BTK-IN-31 (Compound 2) is a selective, non-covalently reversible, and blood-brain barrier (BBB) permeable Btk inhibitor. BTK-IN-31 has research potential in immune disorders, cancer, cardiovascular disease, viral infections, inflammation, metabolic/endocrine dysfunction, and neurological disorders[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
BTK-IN-31 | BTK-IN-31 (Compound 2) is a selective, non-covalently reversible, and blood-brain barrier (BBB) permeable Btk inhibitor. BTK-IN-31 has research potential in immune disorders, cancer, cardiovascular disease, viral infections, inflammation, metabolic/endocrine dysfunction, and neurological disorders. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
